Ролевич А. И. БЕЗРЕЦИДИВНАЯ ВЫЖИВАЕМОСТЬ ПРИ РАКЕ МОЧЕВОГО ПУЗЫРЯ БЕЗ МЫШЕЧНОЙ ИНВАЗИИ. Известия Национальной академии наук Беларуси. Серия медицинских наук. 2016;(4):44-56.
1. Epidemiology and risk factors of urothelial bladder cancer / M. Burger [et al.] // Eur. Urol. – 2013. – Vol. 63, N 2. – P. 234–241.
2. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy / B. W. van Rhijn [et al.] // Eur. Urol. – 2009. – Vol. 56, N 3. – P. 430–442.
3. Falke, J. Contemporary management of low-risk bladder cancer / J. Falke, J. A. Witjes // Nat. Rev. Urol. – 2011. – Vol. 8, N 1. – P. 42–49.
4. The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancer / P. Gontero [et al.] // Eur. Urol. – 2010. – Vol. 57, N 3. – P. 410–429.
5. Richards, K. A. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies / K. A. Richards, N. D. Smith, G. D. Steinberg // J. Urol. – 2014. – Vol. 191, N 6. – P. 1655–1664.
6. Herr, H. W. Role of Repeat Resection in Non-Muscle-Invasive Bladder Cancer / H. W. Herr // J. Nat. Compr. Canc. Netw. – 2015. – Vol. 13, N 8. – P. 1041–1046.
7. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials / R. J. Sylvester [et al.] // Eur. Urol. – 2006. – Vol. 49, N 3. – P. 465–466.
8. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? / R. J. Sylvester [et al.] // Eur. Urol. – 2016. – Vol. 69, N 2. – P. 231–244.
9. Ho, P. L. Immune therapies in non-muscle invasive bladder cancer. / P. L. Ho, S. B. Williams, A. M. Kamat // Curr. Treat. Options Oncol. – 2015. – Vol. 16, N 2. – P. 5.
10. Surgeon has a major impact on long-term recurrence risk in patients with non-muscle invasive bladder cancer /A. I. Rolevich [et al.] // Cent. Eur. J. Urol. – 2016. – Vol. 69. – P. 170–177.
11. Ролевич, А. И. Оценка риска рецидива и прогрессирования при раке мочевого пузыря без мышечной инвазии / А. И. Ролевич, Л. В. Мириленко // Онкоурология. – 2016. – N 4.
12. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. / M. Babjuk [et al.] // Eur. Urol. – 2013. – Vol. 64, N 4. – P. 639–653.
13. ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder / M. Burger [et al.] // Eur. Urol. – 2013. – Vol. 63, N 1. – P. 36–44.
14. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline [Electronic resource] / S. S. Chang [et al.]. – 2016. – Mode of access: https://www.auanet.org/common/pdf/education/clinical-guidance/Non-Muscle-Invasive-Bladder-Cancer.pdf. – Date of access: 19.07.2016.
15. Management of non-muscle invasive bladder cancer: а comprehensive analysis of guidelines from the United States, Europe and Asia / W. S. Tan [et al.] // Cancer. Treat. Rev. – 2016. – Vol. 47. – P. 22–31.
16. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience / P. Mariappan [et al.] // Eur. Urol. – 2010. – Vol. 57, N 5. – P. 843–849.
17. The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience / M. Rouprêt [et al.] // Can. J. Urol. – 2012. – Vol. 19, N 5. –P. 6459–6464.
18. Jancke, G. Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancer / G. Jancke, J. Rosell, S. Jahnson // Scand. J. Urol. – 2014. – Vol. 48, N 3. – P. 276–283.
19. Presence of detrusor muscle in bladder tumor specimens-predictors and effect on outcome as a measure of resection quality / O. Shoshany [et al.] // Urol. Oncol. – 2014. – Vol. 32, N 1. – P. 40.e17–22.
20. Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid inpatients with intermediateand high-risk stage Ta T1 urothelial carcinoma of the bladder / R. J. Sylvester [et al.] // Eur. Urol. – 2010. – Vol. 57, N 5. – P. 766–773.
21. Bacillus Calmette-Guérin is superior to a combination of epirubicin and interferon-alpha2b in the intravesical treatment of patients with stage T1 urinary bladder cancer. A prospective, randomized, Nordic study / M. Duchek [et al.] // Eur. Urol. – 2010. – Vol. 57, N 1. – P. 25–31.
22. Shelley, M. D. Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and metaanalyses / M. D. Shelley, M. D. Mason, H. Kynaston // Cancer Treat. Rev. – 2010. – Vol. 36, N 3. – P. 195–205.
23. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer / P.-U. Malmström [et al.] // Eur. Urol. – 2009. – Vol. 56, N 2. – P. 247–256.
24. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study /M. O. Grimm [et al.] // J. Urol. – 2003. – Vol. 170 (2 Pt 1). – P. 433–437.
25. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial / R. T. Divrik [et al.] // J. Urol. – 2006. – Vol. 175, N 5. – P. 1641–1644.
26. The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin / J. P. Sfakianos [et al.] // J. Urol. – 2014. – Vol. 191, N 2. – P. 341–345.
